Blood purine measurements as a rapid real-time indicator of reversible brain ischaemia.
Journal Information
Full Title: Purinergic Signal
Abbreviation: Purinergic Signal
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosures FT and SB are employed by Sarissa Biomedical Ltd., the manufacturer of the biosensors used in the study and related in vitro diagnostic devices. ND is a Founder and Director of Sarissa Biomedical Ltd., and has equity in this company. Conflicts of interest Faming Tian is an employee of Sarissa Biomedical Ltd and is an inventor on patents that describe methods to measure purines and the use of purine measurements to diagnose ischaemia. Fakhra Bibi is an employee of Sarissa Biomedical Ltd. Nicholas Dale is a Director and Founder of Sarissa Biomedical Ltd, holds equity in that company and is an inventor on patents concerning the detection of purines and their use in diagnosis of ischaemia that are owned or licensed by Sarissa Biomedical. Christopher H. E. Imray is an inventor on patents that cover the use of purine measurements to diagnose ischaemia in a patient."
"University of Warwick"
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025